Content » Vol 74, Issue 6

Clinical Report

Intralesional interferon alpha-2b therapy for Buschke-Loewenstein tumour.

Tsambaos D, Monastirli A, Kapranos N, Georgiou S, Pasmatzi E, Berger H
DOI: 10.2340/0001555574457459

Abstract

A patient with a Buschke-Loewenstein tumour associated with human papillomavirus type 6/11 is reported. He was intralesionally treated with human recombinant alpha-2b interferon (9 x 10(6) IU/day) three times weekly. The tumour completely disappeared within 5 months of continuous treatment which was well tolerated. Sixteen months after completion of therapy the patient remains well and free of disease.

Significance

Supplementary content

Comments

Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.